{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:38:42Z","timestamp":1768703922237,"version":"3.49.0"},"reference-count":71,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MUR program NextGenerationEU","award":["DM 737\/2021-CUP H91121001660006"],"award-info":[{"award-number":["DM 737\/2021-CUP H91121001660006"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Breast cancer (BC) is the most common cancer and the leading cause of cancer death in women worldwide. Since the discovery of the highly penetrant susceptibility genes BRCA1 and BRCA2, many other predisposition genes that confer a moderate risk of BC have been identified. Advances in multigene panel testing have allowed the simultaneous sequencing of BRCA1\/2 with these genes in a cost-effective way. Germline DNA from 521 cases with BC fulfilling diagnostic criteria for hereditary BC were screened with multigene NGS testing. Pathogenic (PVs) and likely pathogenic (LPVs) variants in moderate penetrance genes were identified in 15 out of 521 patients (2.9%), including 2 missense, 7 non-sense, 1 indel, and 3 splice variants, as well as two different exon deletions, as follows: ATM (n = 4), CHEK2 (n = 5), PALB2 (n = 2), RAD51C (n = 1), and RAD51D (n = 3). Moreover, the segregation analysis of PVs and LPVs into first-degree relatives allowed the detection of CHEK2 variant carriers diagnosed with in situ melanoma and clear cell renal cell carcinoma (ccRCC), respectively. Extended testing beyond BRCA1\/2 identified PVs and LPVs in a further 2.9% of BC patients. In conclusion, panel testing yields more accurate genetic information for appropriate counselling, risk management, and preventive options than assessing BRCA1\/2 alone.<\/jats:p>","DOI":"10.3390\/genes14081530","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T01:50:37Z","timestamp":1690422637000},"page":"1530","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of High-to-Moderate Penetrance Genes on Genetic Testing: Looking over Breast Cancer"],"prefix":"10.3390","volume":"14","author":[{"given":"Antonella","family":"Turchiano","sequence":"first","affiliation":[{"name":"Medical Genetic, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilidia","family":"Piglionica","sequence":"additional","affiliation":[{"name":"Medical Genetic, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Martino","sequence":"additional","affiliation":[{"name":"Medical Genetic, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Bagnulo","sequence":"additional","affiliation":[{"name":"Medical Genetic, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Garganese","sequence":"additional","affiliation":[{"name":"Medical Genetic, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annunziata","family":"De Luisi","sequence":"additional","affiliation":[{"name":"Medical Genetic, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5286-5099","authenticated-orcid":false,"given":"Stefania","family":"Chirulli","sequence":"additional","affiliation":[{"name":"Medical Genetic, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4253-4361","authenticated-orcid":false,"given":"Matteo","family":"Iacoviello","sequence":"additional","affiliation":[{"name":"Medical Genetic, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Stasi","sequence":"additional","affiliation":[{"name":"Medical Genetic, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ornella","family":"Tabaku","sequence":"additional","affiliation":[{"name":"Medical Genetic, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Meneleo","sequence":"additional","affiliation":[{"name":"Medical Genetic, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Capurso","sequence":"additional","affiliation":[{"name":"Medical Genetic, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Crocetta","sequence":"additional","affiliation":[{"name":"Medical Genetic, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Lattarulo","sequence":"additional","affiliation":[{"name":"Medical Genetic, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yevheniia","family":"Krylovska","sequence":"additional","affiliation":[{"name":"Medical Genetic, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Lastella","sequence":"additional","affiliation":[{"name":"Rare Disease Center, Internal Medicine Unit \u2018C. Frugoni\u2019, AOU Policlinico di Bari, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9452-4037","authenticated-orcid":false,"given":"Cinzia","family":"Forleo","sequence":"additional","affiliation":[{"name":"Cardiology Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9035-6267","authenticated-orcid":false,"given":"Alessandro","family":"Stella","sequence":"additional","affiliation":[{"name":"Medical Genetic, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9235-8987","authenticated-orcid":false,"given":"Nenad","family":"Bukvic","sequence":"additional","affiliation":[{"name":"Medical Genetic, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano","family":"Simone","sequence":"additional","affiliation":[{"name":"Medical Genetic, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"},{"name":"Medical Genetics, National Institute of Gastroenterology, \u2018S. de Bellis\u2019 Research Hospital, Via Turi 27, Castellana Grotte, 70013 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8640-5532","authenticated-orcid":false,"given":"Nicoletta","family":"Resta","sequence":"additional","affiliation":[{"name":"Medical Genetic, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrc3181","article-title":"BRCA1 and BRCA2: Different Roles in a Common Pathway of Genome Protection","volume":"12","author":"Roy","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.3390\/cancers12092415","article-title":"Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1\/2","volume":"12","author":"Fanale","year":"2020","journal-title":"Cancers"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/cncr.29903","article-title":"Twenty-One-Gene Recurrence Score Assay in BRCA-Associated versus Sporadic Breast Cancers: Differences Based on Germline Mutation Status","volume":"122","author":"Shah","year":"2016","journal-title":"Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa2005936","article-title":"A Population-Based Study of Genes Previously Implicated in Breast Cancer","volume":"384","author":"Hu","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-3-319-70197-4_8","article-title":"Multi-Gene Panel Testing in Breast Cancer Management","volume":"Volume 173","author":"Fountzilas","year":"2018","journal-title":"Optimizing Breast Cancer Management"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jmoldx.2019.03.001","article-title":"Multi-Gene Panel Testing of 23,179 Individuals for Hereditary Cancer Risk Identifies Pathogenic Variant Carriers Missed by Current Genetic Testing Guidelines","volume":"21","author":"Neben","year":"2019","journal-title":"J. Mol. Diagn."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and Accurate Short Read Alignment with Burrows-Wheeler Transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and Accurate Long-Read Alignment with Burrows-Wheeler Transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"key":"ref_12","unstructured":"Van der Auwera, G.A., and O\u2019Connor, B.D. (2020). Genomics in the Cloud: Using Docker, GATK, and WDL in Terra, O\u2019Reilly Media. [1st ed.]."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/humu.22981","article-title":"HGVS Recommendations for the Description of Sequence Variants: 2016 Update","volume":"37","author":"Dalgleish","year":"2016","journal-title":"Hum. Mutat."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJMoa1913948","article-title":"Breast Cancer Risk Genes\u2014Association Analysis in More than 113,000 Women","volume":"384","author":"Dorling","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Toss, A., Tenedini, E., Piombino, C., Venturelli, M., Marchi, I., Gasparini, E., Barbieri, E., Razzaboni, E., Domati, F., and Caggia, F. (2021). Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers. Genes, 12.","DOI":"10.3390\/genes12050616"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/cam4.1376","article-title":"Gene Panel Testing of 5589 BRCA1\/2-Negative Index Patients with Breast Cancer in a Routine Diagnostic Setting: Results of the German Consortium for Hereditary Breast and Ovarian Cancer","volume":"7","author":"Hauke","year":"2018","journal-title":"Cancer Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/cncr.32083","article-title":"Pathogenic and Likely Pathogenic Variants in PALB2, CHEK2, and Other Known Breast Cancer Susceptibility Genes among 1054 BRCA-Negative Hispanics with Breast Cancer","volume":"125","author":"Weitzel","year":"2019","journal-title":"Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.4143\/crt.2021.978","article-title":"Implication and Influence of Multigene Panel Testing with Genetic Counseling in Korean Patients with BRCA1\/2 Mutation-Negative Breast Cancer","volume":"54","author":"Park","year":"2022","journal-title":"Cancer Res. Treat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100235","DOI":"10.1016\/j.esmoop.2021.100235","article-title":"Impact of Deleterious Variants in Other Genes beyond BRCA1\/2 Detected in Breast\/Ovarian and Pancreatic Cancer Patients by NGS-Based Multi-Gene Panel Testing: Looking over the Hedge","volume":"6","author":"Bono","year":"2021","journal-title":"ESMO Open"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ijc.30428","article-title":"Gene Panel Sequencing in Familial Breast\/Ovarian Cancer Patients Identifies Multiple Novel Mutations Also in Genes Others than BRCA1\/2","volume":"140","author":"Kraus","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/ng.893","article-title":"Germline Mutations in RAD51D Confer Susceptibility to Ovarian Cancer","volume":"43","author":"Loveday","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.clbc.2014.08.005","article-title":"Breast Cancer in a RAD51D Mutation Carrier: Case Report and Review of the Literature","volume":"15","author":"Baker","year":"2015","journal-title":"Clin. Breast Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Thompson, E.R., Rowley, S.M., Sawyer, S., Eccles, D.M., Trainer, A.H., Mitchell, G., James, P.A., and Campbell, I.G. (2013). Analysis of RAD51D in Ovarian Cancer Patients and Families with a History of Ovarian or Breast Cancer. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0054772"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ijc.33199","article-title":"Germline Pathogenic Variant Spectrum in 25 Cancer Susceptibility Genes in Turkish Breast and Colorectal Cancer Patients and Elderly Controls","volume":"148","author":"Akcay","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13058-016-0758-5","article-title":"Patient Survival and Tumor Characteristics Associated with CHEK2:P.I157T\u2014Findings from the Breast Cancer Association Consortium","volume":"18","author":"Muranen","year":"2016","journal-title":"Breast Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/jamaoncol.2022.4071","article-title":"Differences in Cancer Phenotypes among Frequent CHEK2 Variants and Implications for Clinical Care\u2014Checking CHEK2","volume":"8","author":"Bychkovsky","year":"2022","journal-title":"JAMA Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1200\/JCO.2017.74.5182","article-title":"Complexities of Variant Classification in Clinical Hereditary Cancer Genetic Testing","volume":"35","author":"Mundt","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1158\/0008-5472.CAN-21-1845","article-title":"Functional Analysis Identifies Damaging CHEK2 Missense Variants Associated with Increased Cancer Risk","volume":"82","author":"Boonen","year":"2022","journal-title":"Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/ijc.32385","article-title":"Identification of Deleterious Germline CHEK2 Mutations and Their Association with Breast and Ovarian Cancer","volume":"145","author":"Kleiblova","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/35071124","article-title":"The ATM-Chk2-Cdc25A Checkpoint Pathway Guards against Radioresistant DNA Synthesis","volume":"410","author":"Falck","year":"2001","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1038\/sj.onc.1204811","article-title":"Functional Impact of Concomitant versus Alternative Defects in the Chk2-P53 Tumour Suppressor Pathway","volume":"20","author":"Falck","year":"2001","journal-title":"Oncogene"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"19389","DOI":"10.1074\/jbc.M200822200","article-title":"Phosphorylation of Threonine 68 Promotes Oligomerization and Autophosphorylation of the Chk2 Protein Kinase via the Forkhead-Associated Domain","volume":"277","author":"Ahn","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/ijc.20299","article-title":"CHEK2 Variant I157T May Be Associated with Increased Breast Cancer Risk","volume":"111","author":"Kilpivaara","year":"2004","journal-title":"Int. J. Cancer"},{"key":"ref_35","first-page":"598","article-title":"Regulation of the Chk2 Protein Kinase by Oligomerization-Mediated Cis- and Trans-Phosphorylation","volume":"1","author":"Schwarz","year":"2003","journal-title":"Mol. Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.molcel.2009.09.007","article-title":"Structure and Activation Mechanism of the CHK2 DNA Damage Checkpoint Kinase","volume":"35","author":"Cai","year":"2009","journal-title":"Mol. Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41431-022-01060-7","article-title":"Consistency of Variant Interpretations among Bioinformaticians and Clinical Geneticists in Hereditary Cancer Panels","volume":"30","author":"Agaoglu","year":"2022","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1186\/bcr3062","article-title":"CHEK2 Contribution to Hereditary Breast Cancer in Non-BRCA Families","volume":"13","author":"Desrichard","year":"2011","journal-title":"Breast Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10549-006-9320-y","article-title":"A Deletion in CHEK2 of 5,395 Bp Predisposes to Breast Cancer in Poland","volume":"102","author":"Cybulski","year":"2007","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1245\/s10434-020-09178-y","article-title":"Bilateral Disease Common among Slovenian CHEK2-Positive Breast Cancer Patients","volume":"28","author":"Krajc","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s42003-021-02990-6","article-title":"Rare Germline Copy Number Variants (CNVs) and Breast Cancer Risk","volume":"5","author":"Dennis","year":"2022","journal-title":"Commun. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s12282-020-01165-1","article-title":"Germline Variants of Brazilian Women with Breast Cancer and Detection of a Novel Pathogenic ATM Deletion in Early-Onset Breast Cancer","volume":"28","author":"Bandeira","year":"2021","journal-title":"Breast Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Parenti, S., Rabacchi, C., Marino, M., Tenedini, E., Artuso, L., Castellano, S., Carretta, C., Mallia, S., Cortesi, L., and Toss, A. (2021). Characterization of New ATM Deletion Associated with Hereditary Breast Cancer. Genes, 12.","DOI":"10.3390\/genes12020136"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41431-017-0021-2","article-title":"Contribution of Germline Deleterious Variants in the RAD51 Paralogs to Breast and Ovarian Cancers \/631\/208\/68 \/631\/67\/1347 Article","volume":"25","author":"Golmard","year":"2017","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s10549-011-1677-x","article-title":"Further Evidence for the Contribution of the RAD51C Gene in Hereditary Breast and Ovarian Cancer Susceptibility","volume":"130","author":"Vuorela","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/bcr3589","article-title":"RAD51C Deletion Screening Identifies a Recurrent Gross Deletion in Breast Cancer and Ovarian Cancer Families","volume":"15","author":"Schnurbein","year":"2013","journal-title":"Breast Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/jnci\/djaa030","article-title":"Ovarian and Breast Cancer Risks Associated with Pathogenic Variants in RAD51C and RAD51D","volume":"112","author":"Yang","year":"2020","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.1158\/1078-0432.CCR-16-3227","article-title":"Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients","volume":"23","author":"Sun","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/s41436-018-0335-7","article-title":"Outcomes of 92 Patient-Driven Family Studies for Reclassification of Variants of Uncertain Significance","volume":"21","author":"Tsai","year":"2019","journal-title":"Genet. Med."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Golmard, L., Caux-Moncoutier, V., Davy, G., Al Ageeli, E., Poirot, B., Tirapo, C., Michaux, D., Barbaroux, C., d\u2019Enghien, C.D., and Nicolas, A. (2013). Germline Mutation in the RAD51B Gene Confers Predisposition to Breast Cancer. BMC Cancer, 13.","DOI":"10.1186\/1471-2407-13-484"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"26798","DOI":"10.1073\/pnas.1915608116","article-title":"Characterization of Splice-Altering Mutations in Inherited Predisposition to Cancer","volume":"116","author":"Casadei","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1200\/JCO.2016.68.4316","article-title":"Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing","volume":"34","author":"Digiovanni","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"19986","DOI":"10.1038\/s41598-019-55515-x","article-title":"Identifying Sequence Variants Contributing to Hereditary Breast and Ovarian Cancer in BRCA1 and BRCA2 Negative Breast and Ovarian Cancer Patients","volume":"9","author":"Jarhelle","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Sanoguera-Miralles, L., Valenzuela-Palomo, A., Bueno-Mart\u00ednez, E., Llovet, P., D\u00edez-G\u00f3mez, B., Caloca, M.J., P\u00e9rez-Segura, P., Fraile-Bethencourt, E., Colmena, M., and Carvalho, S. (2020). Comprehensive Functional Characterization and Clinical Interpretation of 20 Splice-Site Variants of the Rad51c Gene. Cancers, 12.","DOI":"10.3390\/cancers12123771"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/gte.2004.8.235","article-title":"Variants of Uncertain Clinical Significance as a Result of BRCA1\/2 Testing: Impact of an Ambiguous Breast Cancer Risk Message","volume":"8","author":"Jacobi","year":"2004","journal-title":"Genet. Test."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/cge.12097","article-title":"Variants of Uncertain Significance in BRCA Testing: Evaluation of Surgical Decisions, Risk Perception, and Cancer Distress","volume":"84","author":"Culver","year":"2013","journal-title":"Clin. Genet."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/jdv.16729","article-title":"Skin Cancer Risk in CHEK2 Mutation Carriers","volume":"35","author":"Bui","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/gcc.22893","article-title":"Pathogenic Germline Variants in Patients with Features of Hereditary Renal Cell Carcinoma: Evidence for Further Locus Heterogeneity","volume":"60","author":"Smith","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"13518","DOI":"10.1038\/s41598-020-70449-5","article-title":"Prevalence of Pathogenic Variants in DNA Damage Response and Repair Genes in Patients Undergoing Cancer Risk Assessment and Reporting a Personal History of Early-Onset Renal Cancer","volume":"10","author":"Hartman","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e000230","DOI":"10.1136\/jitc-2019-000230","article-title":"DNA Damage Repair Pathway Alterations in Metastatic Clear Cell Renal Cell Carcinoma and Implications on Systemic Therapy","volume":"8","author":"Ged","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/jamaoncol.2018.1986","article-title":"Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients with Advanced Renal Cell Carcinoma","volume":"4","author":"Carlo","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Stolarova, L., Kleiblova, P., Janatova, M., Soukupova, J., Zemankova, P., Macurek, L., and Kleibl, Z. (2020). CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate. Cells, 9.","DOI":"10.3390\/cells9122675"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1086\/426403","article-title":"CHEK2 Is a Multiorgan Cancer Susceptibility Gene","volume":"75","author":"Cybulski","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cancergen.2021.12.007","article-title":"A Founder CHEK2 Pathogenic Variant in Association with Kidney Cancer","volume":"262\u2013263","author":"Brooks","year":"2022","journal-title":"Cancer Genet."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1245\/s10434-020-09158-2","article-title":"Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations","volume":"28","author":"Bergstrom","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1093\/annonc\/mdy338","article-title":"Associations between RAD51D Germline Mutations and Breast Cancer Risk and Survival in BRCA1\/2-Negative Breast Cancers","volume":"29","author":"Chen","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mpdhp.2011.12.003","article-title":"Molecular Classification of Breast Carcinoma","volume":"18","author":"Alizart","year":"2012","journal-title":"Diagn. Histopathol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/his.14808","article-title":"Hereditary Breast Cancer: Syndromes, Tumour Pathology and Molecular Testing","volume":"82","author":"Sokolova","year":"2023","journal-title":"Histopathology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13058-018-0951-9","article-title":"Morphology and Genomic Hallmarks of Breast Tumours Developed by ATM Deleterious Variant Carriers","volume":"20","author":"Renault","year":"2018","journal-title":"Breast Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e216744","DOI":"10.1001\/jamaoncol.2021.6744","article-title":"Pathology of Tumors Associated with Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes","volume":"8","author":"Mavaddat","year":"2022","journal-title":"JAMA Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1002\/cncr.32905","article-title":"Spectrum of PALB2 Germline Mutations and Characteristics of PALB2-Related Breast Cancer: Screening o;f 16,501 Unselected Patients with Breast Cancer and 5890 Controls by next-Generation Sequencing","volume":"126","author":"Zhou","year":"2020","journal-title":"Cancer"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/8\/1530\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:19:35Z","timestamp":1760127575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/8\/1530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":71,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["genes14081530"],"URL":"https:\/\/doi.org\/10.3390\/genes14081530","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,26]]}}}